Germany · Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 56.85 billion. The enterprise value is 65.19 billion.
| Market Cap | 56.85B |
| Enterprise Value | 65.19B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Apr 27, 2026 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 14.69% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 22.43 and the forward PE ratio is 16.02. Merck KGaA's PEG ratio is 1.96.
| PE Ratio | 22.43 |
| Forward PE | 16.02 |
| PS Ratio | 2.71 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 15.38 |
| P/FCF Ratio | 21.51 |
| P/OCF Ratio | 13.55 |
| PEG Ratio | 1.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.49, with an EV/FCF ratio of 24.67.
| EV / Earnings | 25.74 |
| EV / Sales | 3.11 |
| EV / EBITDA | 11.49 |
| EV / EBIT | 16.83 |
| EV / FCF | 24.67 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.40.
| Current Ratio | 1.51 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 4.56 |
| Interest Coverage | 11.22 |
Financial Efficiency
Return on equity (ROE) is 8.53% and return on invested capital (ROIC) is 8.13%.
| Return on Equity (ROE) | 8.53% |
| Return on Assets (ROA) | 4.73% |
| Return on Invested Capital (ROIC) | 8.13% |
| Return on Capital Employed (ROCE) | 8.86% |
| Weighted Average Cost of Capital (WACC) | 7.46% |
| Revenue Per Employee | 354,717 |
| Profits Per Employee | 42,861 |
| Employee Count | 59,077 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.85 |
Taxes
In the past 12 months, Merck KGaA has paid 675.10 million in taxes.
| Income Tax | 675.10M |
| Effective Tax Rate | 20.96% |
Stock Price Statistics
The stock price has increased by +13.20% in the last 52 weeks. The beta is 0.78, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +13.20% |
| 50-Day Moving Average | 115.46 |
| 200-Day Moving Average | 116.64 |
| Relative Strength Index (RSI) | 70.80 |
| Average Volume (20 Days) | 354,869 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 20.96 billion and earned 2.53 billion in profits. Earnings per share was 5.83.
| Revenue | 20.96B |
| Gross Profit | 12.35B |
| Operating Income | 3.87B |
| Pretax Income | 3.22B |
| Net Income | 2.53B |
| EBITDA | 5.67B |
| EBIT | 3.87B |
| Earnings Per Share (EPS) | 5.83 |
Balance Sheet
The company has 3.77 billion in cash and 12.04 billion in debt, with a net cash position of -8.26 billion or -19.01 per share.
| Cash & Cash Equivalents | 3.77B |
| Total Debt | 12.04B |
| Net Cash | -8.26B |
| Net Cash Per Share | -19.01 |
| Equity (Book Value) | 29.82B |
| Book Value Per Share | 68.56 |
| Working Capital | 4.81B |
Cash Flow
In the last 12 months, operating cash flow was 4.19 billion and capital expenditures -1.55 billion, giving a free cash flow of 2.64 billion.
| Operating Cash Flow | 4.19B |
| Capital Expenditures | -1.55B |
| Depreciation & Amortization | 1.80B |
| Net Borrowing | 3.18B |
| Free Cash Flow | 2.64B |
| FCF Per Share | 6.08 |
Margins
Gross margin is 58.93%, with operating and profit margins of 18.49% and 12.08%.
| Gross Margin | 58.93% |
| Operating Margin | 18.49% |
| Pretax Margin | 15.37% |
| Profit Margin | 12.08% |
| EBITDA Margin | 27.08% |
| EBIT Margin | 18.49% |
| FCF Margin | 12.61% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.68%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 1.68% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.75% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 1.83% |
| Earnings Yield | 4.45% |
| FCF Yield | 4.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Merck KGaA is 142.44, which is 8.73% higher than the current price. The consensus rating is "Buy".
| Price Target | 142.44 |
| Price Target Difference | 8.73% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 2.7 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 5 |